List of works - Marta Szajnik

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

scientific article published on 17 August 2012

Abstract 3975: Ovarian cancer cells release arginase-1-containing exosomes to suppress antitumor immune response

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells

scientific article

Antagonism of tumoral prolactin receptor promotes autophagy-related cell death

scientific article

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

scientific article published on 8 June 2016

Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1 ⬇️

scientific article published on May 23, 2011

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

scientific article

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy

scientific article published on April 2013

Expression of survivin, SDF-1 and CXCR4 on tumor cells in ovarian cancer

scientific article published on 01 September 2010

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

scientific article

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer

scientific article published on 13 October 2009

Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia

scientific article published on 05 May 2009

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

scientific article

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

scientific article published on 23 December 2010

Mechanisms of tumor escape from the immune system: Adenosine-producing Treg, exosomes and tumor-associated TLRs ⬇️

scientific article published on February 1, 2011

Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

scientific article published on 12 March 2010

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

scientific article

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

scientific article published on 24 March 2009

Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

scientific article

Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes

scientific article

[Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues]

scientific article published on 01 December 2007

List of works by Marta Szajnik

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

Abstract 3975: Ovarian cancer cells release arginase-1-containing exosomes to suppress antitumor immune response

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells

Antagonism of tumoral prolactin receptor promotes autophagy-related cell death

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1 ⬇️

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy

Expression of survivin, SDF-1 and CXCR4 on tumor cells in ovarian cancer

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer

Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

Mechanisms of tumor escape from the immune system: Adenosine-producing Treg, exosomes and tumor-associated TLRs ⬇️

Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes

[Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues]